PRECISE-HD
Pridopidine Phase 3 Study in Huntington's Disease
Phase 3 study testing pridopidine to see whether it can slow the progression of Huntington's disease.
RecruitingPhase 3DrugClinicalTrials.govTreatment trial
Recruiting in: Aachen, Aberdeen, Anderlecht +61 more (Belgium, Canada, Czechia +9 more)
Sponsor: Prilenia
Preparing a short plain-English summary.